Protocol of Pakistan randomized and observational trial to evaluate coronavirus treatment among newly diagnosed patients with COVID-19: Azithromycin, Oseltamivir, and Hydroxychloquine

BACKGROUND & OBJECTIVE: This study aimed to assess the clinical effectiveness of Hydroxychloroquine Sulfate (200 mg orally 8 hourlies thrice a day for 5 days), oseltamivir (75 mg orally twice a day for 5 days), and Azithromycin (500 mg orally daily on day 1, followed by 250 mg orally twice a day...

Descripción completa

Detalles Bibliográficos
Autores principales: Azhar, Shehnoor, Akram, Javed, Shahzad, Muhammad, Latif, Waqas, Khan, Khalid Saeed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Professional Medical Publications 2022
Materias:
Special Communication/Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9247782/
https://www.ncbi.nlm.nih.gov/pubmed/35799756
http://dx.doi.org/10.12669/pjms.38.5.5512

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9247782/
https://www.ncbi.nlm.nih.gov/pubmed/35799756
http://dx.doi.org/10.12669/pjms.38.5.5512

Ejemplares similares